Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Gastrointestinal Mucosal Damage
Interventions
DRUG

Ibuprofen

Liquid gelation capsules or tablets of 400 mg strength

DRUG

Paracetamol

Paracetamol fast dissolving tablets of 500 mg strength

OTHER

Placebo

Placebo tablets

Trial Locations (1)

77074

Houston Institute for Clinical Research, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01822665 - Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics | Biotech Hunter | Biotech Hunter